543444 — Fabino Life Sciences Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Fabino Life Sciences Ltd is an India-based pharmaceutical company. The Company offers a range of allopathic and herbal products. Its product categories include allopathic products, Covid-19 products, food supplements, herbal products, multi-vitamin products, and veterinary products. Its allopathic products include AMOXRAG-625, Astrid Syrup, Aurceta AM, Aurifox OZ, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Ceporag O, Doref M, Dr-DSR, F Plexus A, and Fabpara. Its Covid-19 products include disposable face shield, fabclean hand sanitizer, mask, and personal protective equipment (PPE). Its herbal products include Aurcis-Forte, Aurzyme-Syrup, Ayush Kadha, Coptec-syrup, Cough-Free, DStoren-Syrup, Ecstasy Tilla Oil, Fablactin, Giloy Power, Keepshine Hair Oil, Onion Hair Oil, Pain-Go, Power Malt, Regaliv-ds, Sandy Forte and M-Sharp-Brain-tonic. Its Multi-Vitamin products include Aur D3 Capsules, Coptec Capsules, FABZYM CAPSULE, Oshnine Plus, and Rigovit Softgel Capsules.
Directors
- Last Annual
- Last Interim
- Incorporated
- October 27th, 2011
- Public Since
- January 13th, 2022
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 1
- Address
- B-Wing, NEW DELHI, 110085
- Web
- https://www.fabinolife.com/
- Phone
- Auditors
Similar to 543444
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 19:08 UTC, shares in Fabino Life Sciences are trading at IN₹26.28. This share price information is delayed by 15 minutes.
Shares in Fabino Life Sciences last closed at IN₹26.28 and the price had moved by -17.88% over the past 365 days. In terms of relative price strength the Fabino Life Sciences share price has underperformed the S&P BSE 100 Index by -33.83% over the past year.
There is no consensus recommendation for this security.
Fabino Life Sciences does not currently pay a dividend.
Fabino Life Sciences does not currently pay a dividend.
Fabino Life Sciences does not currently pay a dividend.
To buy shares in Fabino Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹26.28, shares in Fabino Life Sciences had a market capitalisation of .
Here are the trading details for Fabino Life Sciences:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 543444
Based on an overall assessment of its quality, value and momentum Fabino Life Sciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fabino Life Sciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -17.89%.
As of the last closing price of IN₹26.28, shares in Fabino Life Sciences were trading -14.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Fabino Life Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹26.28.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Fabino Life Sciences' directors